Constance Young
Family · Bonne Terre, MONPI 1891767125
Payments from drug & device makers
Across 193 payments — averaging $18.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$469
- AstraZeneca$348
- Otsuka America Pharmaceutical, Inc.$188
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$152
- Teva Pharmaceuticals USA, Inc.$139
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,650100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 69 | $1,213 |
| Novo Nordisk | 26 | $469 |
| AstraZeneca | 20 | $348 |
| Otsuka America Pharmaceutical, Inc. | 7 | $188 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $152 |
| Teva Pharmaceuticals USA, Inc. | 2 | $139 |
| GSK | 9 | $138 |
| Johnson & Johnson | 2 | $120 |
| Boehringer Ingelheim | 5 | $85 |
| Bayer | 4 | $69 |
| Lilly USA, LLC | 4 | $69 |
| Phathom Pharmaceuticals, Inc. | 4 | $66 |
| Neurocrine Biosciences, Inc. | 1 | $66 |
| Novartis | 4 | $65 |
| Pfizer | 3 | $59 |
| Globus Medical | 3 | $53 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $44 |
| Nevro Corp. | 2 | $40 |
| Amgen | 2 | $35 |
| Lundbeck LLC | 2 | $33 |
| Exact Sciences | 2 | $32 |
| Axsome Therapeutics, Inc. | 2 | $32 |
| Amarin Pharma, Inc. | 2 | $27 |
| Corcept Therapeutics | 1 | $23 |
| Tactile Systems Technology Inc | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Abbott | 1 | $14 |
How this compares
$3,650 in reported general payments places this provider in the 85th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 300 | $332,398 |
| FarxigaDapagliflozin Propanediol | 277 | $194,160 |
| JardianceEmpagliflozin | 192 | $145,796 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 106 | $85,789 |
| RybelsusSemaglutide | 70 | $83,318 |
| VraylarCariprazine Hcl | 39 | $57,884 |
| VascepaIcosapent Ethyl | 117 | $55,140 |
| RexultiBrexpiprazole | 31 | $52,487 |
| TrulicityDulaglutide | 43 | $45,710 |
| XareltoRivaroxaban | 59 | $37,001 |
| EliquisApixaban | 52 | $34,838 |
| Tresiba Flextouch U-200Insulin Degludec | 21 | $32,378 |
| LinzessLinaclotide | 20 | $21,755 |
| MyrbetriqMirabegron | 37 | $19,891 |
| Nurtec OdtRimegepant Sulfate | 16 | $17,752 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $469 | $415,716370 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $348 | $201,142288 claims |
| Boehringer IngelheimJardiance | $85 | $145,796192 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Arexvy, Breo Ellipta | $138 | $116,477178 claims |
| AbbVieVraylar, Linzess | $1,213 | $79,63959 claims |
| PfizerEliquis, Nurtec Odt, Premarin | $59 | $57,35583 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $69 | $56,76754 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $188 | $52,48731 claims |
| Johnson & JohnsonXarelto | $120 | $37,00159 claims |
| NovartisEntresto | $65 | $13,39420 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $16 | $5,91412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,812 family providers in Missouri.
Other family in Bonne Terre
- Connie SpencerSaint Joseph$320K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.